|
[1] PAIK JM,GOLABI P,YOUNOSSI Y,et al. Changes in the global burden of chronic liver diseases from 2012 to 2017:The growing impact of nonalcoholic fatty liver disease[J]. Hepatology,2020.[Online ahead of print]
|
|
[2] SARIN SK,KUMAR M,ESLAM M,et al. Liver diseases in the Asia-Pacific region:A Lancet Gastroenterology&Hepatology Commission[J]. Lancet Gastroenterol Hepatol,2020,5(2):167-228.
|
|
[3] GABRILOVICH DI,BRONTE V,CHEN SH,et al. The terminology issue for myeloid-derived suppressor cells[J]. Cancer Res,2007,67(1):425; author reply 426.
|
|
[4] MI Y,GUO N,LUAN J,et al. The emerging role of myeloidderived suppressor cells in the glioma immune suppressive microenvironment[J]. Front Immunol,2020,11:737.
|
|
[5] NAKAMURA T,USHIGOME H. Myeloid-derived suppressor cells as a regulator of immunity in organ transplantation[J]. Int J Mol Sci,2018,19(8):2357.
|
|
[6] GAO Y,SUN W,SHANG W,et al. Lnc-C/EBPβnegatively regulates the suppressive function of myeloid-derived suppressor cells[J]. Cancer Immunol Res,2018,6(11):1352-1363.
|
|
[7] ELLIOTT DM,SINGH N,NAGARKATTI M,et al. Cannabidiol attenuates experimental autoimmune encephalomyelitis model of multiple sclerosis through induction of myeloid-derived suppressor cells[J]. Front Immunol,2018,9:1782.
|
|
[8] TANG CH,CHANG S,HASHIMOTO A,et al. Secretory IgM exacerbates tumor progression by inducing accumulations of MDSCs in mice[J]. Cancer Immunol Res,2018,6(6):696-710.
|
|
[9] LIU YF,ZHUANG KH,CHEN B,et al. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis[J]. Arthritis Res Ther,2018,20(1):168.
|
|
[10] CROAGH CM,LUBEL JS. Natural history of chronic hepatitis B:Phases in a complex relationship[J]. World J Gastroenterol,2014,20(30):10395-10404.
|
|
[11] FANG Z,LI J,YU X,et al. Polarization of monocytic myeloid-derived suppressor cells by hepatitis B surface antigen is mediated via ERK/IL-6/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection[J]. J Immunol,2015,195(10):4873-4883.
|
|
[12] PAL S,NANDI M,DEY D,et al. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy[J]. Aliment Pharmacol Ther,2019,49(10):1346-1359.
|
|
[13] LV Y,CUI M,LV Z,et al. Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients[J]. Clin Res Hepatol Gastroenterol,2018,42(5):462-469.
|
|
[14] HUANG A,ZHANG B,YAN W,et al. Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10[J]. J Immunol,2014,193(11):5461-5469.
|
|
[15] KONG X,SUN R,CHEN Y,et al．γδT cells drive myeloidderived suppressor cell-mediated CD8+T cell exhaustion in hepatitis B virus-induced immunotolerance[J]. J Immunol,2014,193(4):1645-1653.
|
|
[16] YANG F,YU X,ZHOU C,et al. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection[J]. PLo S Pathog,2019,15(4):e1007690.
|
|
[17] WEBER C. Hepatitis:Myeloid-derived suppressor cells in HBV infection[J]. Nat Rev Gastroenterol Hepatol,2015,12(7):370.
|
|
[18] PALLETT LJ,GILL US,QUAGLIA A,et al. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells[J]. Nat Med,2015,21(6):591-600.
|
|
[19] ZENG Y,LI Y,XU Z,et al. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure[J].J Med Virol,2019,91(8):1510-1518.
|
|
[20] ZHENG Z,SZE CW,KENG CT,et al. Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model[J]. PLo S One,2017,12(9):e0184127.
|
|
[21] TACKE RS,LEE HC,GOH C,et al. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species[J]. Hepatology,2012,55(2):343-353.
|
|
[22] WANG L,CAO D,WANG L,et al. HCV-associated exosomes promote myeloid-derived suppressor cell expansion via inhibiting miR-124 to regulate T follicular cell differentiation and function[J]. Cell Discov,2018,4:51.
|
|
[23] WANG M,PING Y,LI Z,et al. Polarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10/STAT3 signalling[J]. J Viral Hepat,2019,26(2):246-257.
|
|
[24] GOH CC,ROGGERSON KM,LEE HC,et al. Hepatitis C virus-induced myeloid-derived suppressor cells suppress NK cell IFN-γproduction by altering cellular metabolism via arginase-1[J]. J Immunol,2016,196(5):2283-2292.
|
|
[25] TELATIN V,NICOLI F,FRASSON C,et al. In chronic hepatitis C infection,myeloid-derived suppressor cell accumulation and T cell dysfunctions revert partially and late after successful direct-acting antiviral treatment[J]. Front Cell Infect Microbiol,2019,9:190.
|
|
[26] WANG H,MA L,YIN Q,et al. Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China[J]. Alcohol Clin Exp Res,2014,38(4):1035-1041.
|
|
[27] GAO B,AHMAD MF,NAGY LE,et al. Inflammatory pathways in alcoholic steatohepatitis[J]. J Hepatol,2019,70(2):249-259.
|
|
[28] LI S,WANG N,TAN HY,et al. Expansion of granulocytic,myeloid-derived suppressor cells in response to ethanol-induced acute liver damage[J]. Front Immunol,2018,9:1524.
|
|
[29] GAO M,HUANG A,SUN Z,et al. Granulocytic myeloid-derived suppressor cell population increases with the severity of alcoholic liver disease[J]. J Cell Mol Med,2019,23(3):2032-2041.
|
|
[30] TSUNASHIMA H,TSUNEYAMA K,MORITOKI Y,et al. Accumulated myeloid-derived suppressor cells demonstrate distinct phenotypes and functions in two non-alcoholic steatohepatitis mouse models[J]. Hepatobiliary Surg Nutr,2015,4(5):313-319.
|
|
[31] YAO L,ABE M,KAWASAKI K,et al. Characterization of liver monocytic myeloid-derived suppressor cells and their role in a murine model of non-alcoholic fatty liver disease[J]. PLo S One,2016,11(2):e0149948.
|
|
[32] SRIVASTAVA N,IYER S,SUDAN R,et al. A small-molecule inhibitor of SHIP1 reverses age-and diet-associated obesity and metabolic syndrome[J]. JCI Insight,2016,1(11).
|
|
[33] OHL K,TENBROCK K. Reactive oxygen species as regulators of MDSC-mediated immune suppression[J]. Front Immunol,2018,9:2499.
|
|
[34] LIBERAL R,MIELI-VERGANI G,VERGANI D. Autoimmune hepatitis:From mechanisms to therapy[J]. Rev Clin Esp,2016,216(7):372-383.
|
|
[35] HSIEH CC,HUNG CH,LU L,et al. Hepatic immune tolerance induced by hepatic stellate cells[J]. World J Gastroenterol,2015,21(42):11887-11892.
|
|
[36] LI H,DAI F,PENG Q,et al. Myeloid-derived suppressor cells suppress CD4+and CD8+T cell responses in autoimmune hepatitis[J]. Mol Med Rep,2015,12(3):3667-3673.
|
|
[37] CHEN X,ZHANG Z,BI Y,et al. m TOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway[J]. J Leukoc Biol,2016,100(6):1349-1362.
|
|
[38] HAMMERICH L,WARZECHA KT,STEFKOVA M,et al. Cyclic adenosine monophosphate-responsive element modulator alpha overexpression impairs function of hepatic myeloid-derived suppressor cells and aggravates immune-mediated hepatitis in mice[J]. Hepatology,2015,61(3):990-1002.
|
|
[39] LIAN M,ZHANG J,ZHAO L,et al. Interleukin-35 regulates immune microenvironment of autoimmune hepatitis through inducing the expansion of myeloid-derived suppressor cells[J]. Front Immunol,2019,10:2577.
|
|
[40] BRAY F,FERLAY J,SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
|
|
[41] ZHANG H,HE G,KONG Y,et al. Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver[J]. Clin Exp Immunol,2017,188(1):96-108.
|
|
[42] ELWAN N,SALEM ML,KOBTAN A,et al. High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients[J]. Immunol Invest,2018,47(2):169-180.
|
|
[43] NAN J,XING YF,HU B,et al. Endoplasmic reticulum stress induced LOX-1+CD15+polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma[J]. Immunology,2018,154(1):144-155.
|
|
[44] YU SJ,MA C,HEINRICH B,et al. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma[J]. J Hepatol,2019,70(3):449-457.
|
|
[45] LACOTTE S,SLITS F,ORCI LA,et al. Impact of myeloidderived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma[J]. Oncoimmunology, 2016, 5(11):e1234565.
|
|
[46] DENG Y,CHENG J,FU B,et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells[J]. Oncogene,2017,36(8):1090-1101.
|
|
[47] XU Y,FANG F,JIAO H,et al. Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma[J].Cancer Immunol Immunother,2019,68(12):1959-1969.
|
|
[48] LU LC,CHANG CJ,HSU CH. Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma:Current state and future perspectives[J]. J Hepatocell Carcinoma,2019,6:71-84.
|
|
[49] HSIEH CC,HUNG CH,CHIANG M,et al. Hepatic stellate cells enhance liver cancer progression by inducing myeloidderived suppressor cells through interleukin-6 signaling[J].Int J Mol Sci,2019,20(20):5079.
|
DownLoad: